世界の神経学的lバイオマーカー市場:メーカー別、地域別、種類別、用途別、市場予測

◆英語タイトル:Global Neurological Biomarkers Market by Manufacturers, Countries, Type and Application, Forecast to 2022
◆商品コード:GIR8030373
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2018年2月
◆ページ数:115
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:世界
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥382,800見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD4,680 ⇒換算¥514,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、神経学的lバイオマーカーの世界市場について調査・分析し、神経学的lバイオマーカーの世界市場概観、メーカー動向、メーカー別神経学的lバイオマーカーシェア、市場規模推移、市場規模予測、神経学的lバイオマーカー種類別分析(プロテオミクス、ゲノミクス、画像、バイオインフォマティクス、その他)、神経学的lバイオマーカー用途別分析(診断、薬品開発、パーソナライズ薬品、その他)、主要地域分析(北米、欧州、アジア)、主要国分析データなどを含め、以下の構成でお届け致します。
・神経学的lバイオマーカーの市場概観
・神経学的lバイオマーカーのメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・神経学的lバイオマーカーのメーカー別販売動向、市場シェア、市場集中度、競争動向
・神経学的lバイオマーカーの世界市場規模
・神経学的lバイオマーカーの北米市場分析(アメリカ、カナダ、メキシコ等)
・神経学的lバイオマーカーのアメリカ市場規模推移
・神経学的lバイオマーカーのカナダ市場規模推移
・神経学的lバイオマーカーのメキシコ市場規模推移
・神経学的lバイオマーカーのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・神経学的lバイオマーカーのドイツ市場規模推移
・神経学的lバイオマーカーのイギリス市場規模推移
・神経学的lバイオマーカーのロシア市場規模推移
・神経学的lバイオマーカーのアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・神経学的lバイオマーカーの日本市場規模推移
・神経学的lバイオマーカーの中国市場規模推移
・神経学的lバイオマーカーの韓国市場規模推移
・神経学的lバイオマーカーのインド市場規模推移
・神経学的lバイオマーカーの東南アジア市場規模推移
・神経学的lバイオマーカーの南米・中東・アフリカ市場分析
・神経学的lバイオマーカーの種類別分析/市場規模推移(プロテオミクス、ゲノミクス、画像、バイオインフォマティクス、その他)
・神経学的lバイオマーカーの用途別分析/市場規模推移(診断、薬品開発、パーソナライズ薬品、その他)
・神経学的lバイオマーカーの市場予測(地域別予測、種類別予測、用途別予測)
・神経学的lバイオマーカーの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus. In the era of molecular medicine, biomarkers usually mean molecular biomarkers and can be divided into 3 broad categories

Scope of the Report:
This report focuses on the Neurological Biomarkers in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Thermo Fisher
Merck
Bio-Rad Laboratories
Roche
QIAGEN
Athena Diagnostics
Myriad RBM
Cisbio Bioassays
Wuxi APP
BGI
Aepodia
Genewiz
Proteome Sciences

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Proteomics
Genomics
Imaging
Bioinformatics
Others

Market Segment by Applications, can be divided into
Diagnostics
Drug Discovery
Personalized Medicine
Others

There are 15 Chapters to deeply display the global Neurological Biomarkers market.

Chapter 1, to describe Neurological Biomarkers Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Neurological Biomarkers, with sales, revenue, and price of Neurological Biomarkers, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Neurological Biomarkers, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Neurological Biomarkers market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Neurological Biomarkers sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Neurological Biomarkers Introduction
1.2 Market Analysis by Type
1.2.1 Proteomics
1.2.2 Genomics
1.2.3 Imaging
1.2.4 Bioinformatics
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Diagnostics
1.3.2 Drug Discovery
1.3.3 Personalized Medicine
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Thermo Fisher
2.1.1 Business Overview
2.1.2 Neurological Biomarkers Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Thermo Fisher Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Neurological Biomarkers Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bio-Rad Laboratories
2.3.1 Business Overview
2.3.2 Neurological Biomarkers Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Roche
2.4.1 Business Overview
2.4.2 Neurological Biomarkers Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 QIAGEN
2.5.1 Business Overview
2.5.2 Neurological Biomarkers Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Athena Diagnostics
2.6.1 Business Overview
2.6.2 Neurological Biomarkers Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Myriad RBM
2.7.1 Business Overview
2.7.2 Neurological Biomarkers Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cisbio Bioassays
2.8.1 Business Overview
2.8.2 Neurological Biomarkers Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Wuxi APP
2.9.1 Business Overview
2.9.2 Neurological Biomarkers Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 BGI
2.10.1 Business Overview
2.10.2 Neurological Biomarkers Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Aepodia
2.11.1 Business Overview
2.11.2 Neurological Biomarkers Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Genewiz
2.12.1 Business Overview
2.12.2 Neurological Biomarkers Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Proteome Sciences
2.13.1 Business Overview
2.13.2 Neurological Biomarkers Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Neurological Biomarkers Market Competition, by Manufacturer
3.1 Global Neurological Biomarkers Sales and Market Share by Manufacturer
3.2 Global Neurological Biomarkers Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Neurological Biomarkers Manufacturer Market Share
3.3.2 Top 6 Neurological Biomarkers Manufacturer Market Share
3.4 Market Competition Trend
4 Global Neurological Biomarkers Market Analysis by Regions
4.1 Global Neurological Biomarkers Sales, Revenue and Market Share by Regions
4.1.1 Global Neurological Biomarkers Sales by Regions (2012-2017)
4.1.2 Global Neurological Biomarkers Revenue by Regions (2012-2017)
4.2 North America Neurological Biomarkers Sales and Growth (2012-2017)
4.3 Europe Neurological Biomarkers Sales and Growth (2012-2017)
4.4 Asia-Pacific Neurological Biomarkers Sales and Growth (2012-2017)
4.5 South America Neurological Biomarkers Sales and Growth (2012-2017)
4.6 Middle East and Africa Neurological Biomarkers Sales and Growth (2012-2017)
5 North America Neurological Biomarkers by Countries
5.1 North America Neurological Biomarkers Sales, Revenue and Market Share by Countries
5.1.1 North America Neurological Biomarkers Sales by Countries (2012-2017)
5.1.2 North America Neurological Biomarkers Revenue by Countries (2012-2017)
5.2 USA Neurological Biomarkers Sales and Growth (2012-2017)
5.3 Canada Neurological Biomarkers Sales and Growth (2012-2017)
5.4 Mexico Neurological Biomarkers Sales and Growth (2012-2017)
6 Europe Neurological Biomarkers by Countries
6.1 Europe Neurological Biomarkers Sales, Revenue and Market Share by Countries
6.1.1 Europe Neurological Biomarkers Sales by Countries (2012-2017)
6.1.2 Europe Neurological Biomarkers Revenue by Countries (2012-2017)
6.2 Germany Neurological Biomarkers Sales and Growth (2012-2017)
6.3 UK Neurological Biomarkers Sales and Growth (2012-2017)
6.4 France Neurological Biomarkers Sales and Growth (2012-2017)
6.5 Russia Neurological Biomarkers Sales and Growth (2012-2017)
6.6 Italy Neurological Biomarkers Sales and Growth (2012-2017)
7 Asia-Pacific Neurological Biomarkers by Countries
7.1 Asia-Pacific Neurological Biomarkers Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Neurological Biomarkers Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Neurological Biomarkers Revenue by Countries (2012-2017)
7.2 China Neurological Biomarkers Sales and Growth (2012-2017)
7.3 Japan Neurological Biomarkers Sales and Growth (2012-2017)
7.4 Korea Neurological Biomarkers Sales and Growth (2012-2017)
7.5 India Neurological Biomarkers Sales and Growth (2012-2017)
7.6 Southeast Asia Neurological Biomarkers Sales and Growth (2012-2017)
8 South America Neurological Biomarkers by Countries
8.1 South America Neurological Biomarkers Sales, Revenue and Market Share by Countries
8.1.1 South America Neurological Biomarkers Sales by Countries (2012-2017)
8.1.2 South America Neurological Biomarkers Revenue by Countries (2012-2017)
8.2 Brazil Neurological Biomarkers Sales and Growth (2012-2017)
8.3 Argentina Neurological Biomarkers Sales and Growth (2012-2017)
8.4 Columbia Neurological Biomarkers Sales and Growth (2012-2017)
9 Middle East and Africa Neurological Biomarkers by Countries
9.1 Middle East and Africa Neurological Biomarkers Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Neurological Biomarkers Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Neurological Biomarkers Revenue by Countries (2012-2017)
9.2 Saudi Arabia Neurological Biomarkers Sales and Growth (2012-2017)
9.3 UAE Neurological Biomarkers Sales and Growth (2012-2017)
9.4 Egypt Neurological Biomarkers Sales and Growth (2012-2017)
9.5 Nigeria Neurological Biomarkers Sales and Growth (2012-2017)
9.6 South Africa Neurological Biomarkers Sales and Growth (2012-2017)
10 Global Neurological Biomarkers Market Segment by Type
10.1 Global Neurological Biomarkers Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Neurological Biomarkers Sales and Market Share by Type (2012-2017)
10.1.2 Global Neurological Biomarkers Revenue and Market Share by Type (2012-2017)
10.2 Proteomics Sales Growth and Price
10.2.1 Global Proteomics Sales Growth (2012-2017)
10.2.2 Global Proteomics Price (2012-2017)
10.3 Genomics Sales Growth and Price
10.3.1 Global Genomics Sales Growth (2012-2017)
10.3.2 Global Genomics Price (2012-2017)
10.4 Imaging Sales Growth and Price
10.4.1 Global Imaging Sales Growth (2012-2017)
10.4.2 Global Imaging Price (2012-2017)
10.5 Bioinformatics Sales Growth and Price
10.5.1 Global Bioinformatics Sales Growth (2012-2017)
10.5.2 Global Bioinformatics Price (2012-2017)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2012-2017)
10.6.2 Global Others Price (2012-2017)
11 Global Neurological Biomarkers Market Segment by Application
11.1 Global Neurological Biomarkers Sales Market Share by Application (2012-2017)
11.2 Diagnostics Sales Growth (2012-2017)
11.3 Drug Discovery Sales Growth (2012-2017)
11.4 Personalized Medicine Sales Growth (2012-2017)
11.5 Others Sales Growth (2012-2017)
12 Neurological Biomarkers Market Forecast (2017-2022)
12.1 Global Neurological Biomarkers Sales, Revenue and Growth Rate (2017-2022)
12.2 Neurological Biomarkers Market Forecast by Regions (2017-2022)
12.2.1 North America Neurological Biomarkers Market Forecast (2017-2022)
12.2.2 Europe Neurological Biomarkers Market Forecast (2017-2022)
12.2.3 Asia-Pacific Neurological Biomarkers Market Forecast (2017-2022)
12.2.4 South America Neurological Biomarkers Market Forecast (2017-2022)
12.2.5 Middle East and Africa Neurological Biomarkers Market Forecast (2017-2022)
12.3 Neurological Biomarkers Market Forecast by Type (2017-2022)
12.4 Neurological Biomarkers Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List of Tables and Figures

Figure Neurological Biomarkers Picture
Table Product Specifications of Neurological Biomarkers
Figure Global Sales Market Share of Neurological Biomarkers by Types in 2016
Table Neurological Biomarkers Types for Major Manufacturers
Figure Proteomics Picture
Figure Genomics Picture
Figure Imaging Picture
Figure Bioinformatics Picture
Figure Others Picture
Table Neurological Biomarkers Sales Market Share by Applications in 2016
Figure Diagnostics Picture
Figure Drug Discovery Picture
Figure Personalized Medicine Picture
Figure Others Picture
Figure USA Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure France Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure UK Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure China Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure India Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Table Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Neurological Biomarkers Type and Applications
Table Thermo Fisher Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Neurological Biomarkers Type and Applications
Table Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table Bio-Rad Laboratories Neurological Biomarkers Type and Applications
Table Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Neurological Biomarkers Type and Applications
Table Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table QIAGEN Basic Information, Manufacturing Base and Competitors
Table QIAGEN Neurological Biomarkers Type and Applications
Table QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Athena Diagnostics Basic Information, Manufacturing Base and Competitors
Table Athena Diagnostics Neurological Biomarkers Type and Applications
Table Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Myriad RBM Basic Information, Manufacturing Base and Competitors
Table Myriad RBM Neurological Biomarkers Type and Applications
Table Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cisbio Bioassays Basic Information, Manufacturing Base and Competitors
Table Cisbio Bioassays Neurological Biomarkers Type and Applications
Table Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Wuxi APP Basic Information, Manufacturing Base and Competitors
Table Wuxi APP Neurological Biomarkers Type and Applications
Table Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BGI Basic Information, Manufacturing Base and Competitors
Table BGI Neurological Biomarkers Type and Applications
Table BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aepodia Basic Information, Manufacturing Base and Competitors
Table Aepodia Neurological Biomarkers Type and Applications
Table Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genewiz Basic Information, Manufacturing Base and Competitors
Table Genewiz Neurological Biomarkers Type and Applications
Table Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Proteome Sciences Basic Information, Manufacturing Base and Competitors
Table Proteome Sciences Neurological Biomarkers Type and Applications
Table Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Neurological Biomarkers Sales by Manufacturer (2016-2017)
Figure Global Neurological Biomarkers Sales Market Share by Manufacturer in 2016
Figure Global Neurological Biomarkers Sales Market Share by Manufacturer in 2017
Table Global Neurological Biomarkers Revenue by Manufacturer (2016-2017)
Figure Global Neurological Biomarkers Revenue Market Share by Manufacturer in 2016
Figure Global Neurological Biomarkers Revenue Market Share by Manufacturer in 2017
Figure Global Neurological Biomarkers Sales and Growth (2012-2017)
Figure Global Neurological Biomarkers Revenue and Growth (2012-2017)
Table Global Neurological Biomarkers Sales by Regions (2012-2017)
Table Global Neurological Biomarkers Sales Market Share by Regions (2012-2017)
Table Global Neurological Biomarkers Revenue by Regions (2012-2017)
Table Global Neurological Biomarkers Revenue Market Share by Regions in 2012
Table Global Neurological Biomarkers Revenue Market Share by Regions in 2016
Figure North America Neurological Biomarkers Sales and Growth (2012-2017)
Figure Europe Neurological Biomarkers Sales and Growth (2012-2017)
Figure Asia-Pacific Neurological Biomarkers Sales and Growth (2012-2017)
Figure South America Neurological Biomarkers Sales and Growth (2012-2017)
Figure Middle East and Africa Neurological Biomarkers Sales and Growth (2012-2017)
Figure North America Neurological Biomarkers Revenue and Growth (2012-2017)
Table North America Neurological Biomarkers Sales by Countries (2012-2017)
Table North America Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Figure North America Neurological Biomarkers Sales Market Share by Countries in 2012
Figure North America Neurological Biomarkers Sales Market Share by Countries in 2016
Table North America Neurological Biomarkers Revenue by Countries (2012-2017)
Table North America Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure North America Neurological Biomarkers Revenue Market Share by Countries in 2012
Figure North America Neurological Biomarkers Revenue Market Share by Countries in 2016
Figure USA Neurological Biomarkers Sales and Growth (2012-2017)
Figure Canada Neurological Biomarkers Sales and Growth (2012-2017)
Figure Mexico Neurological Biomarkers Sales and Growth (2012-2017)
Figure Europe Neurological Biomarkers Revenue and Growth (2012-2017)
Table Europe Neurological Biomarkers Sales by Countries (2012-2017)
Table Europe Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Table Europe Neurological Biomarkers Revenue by Countries (2012-2017)
Table Europe Neurological Biomarkers Revenue Market Share by Countries in 2012
Table Europe Neurological Biomarkers Revenue Market Share by Countries in 2016
Figure Germany Neurological Biomarkers Sales and Growth (2012-2017)
Figure UK Neurological Biomarkers Sales and Growth (2012-2017)
Figure France Neurological Biomarkers Sales and Growth (2012-2017)
Figure Russia Neurological Biomarkers Sales and Growth (2012-2017)
Figure Italy Neurological Biomarkers Sales and Growth (2012-2017)
Figure Asia-Pacific Neurological Biomarkers Revenue and Growth (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales by Countries (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Neurological Biomarkers Revenue by Countries (2012-2017)
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure China Neurological Biomarkers Sales and Growth (2012-2017)
Figure Japan Neurological Biomarkers Sales and Growth (2012-2017)
Figure Korea Neurological Biomarkers Sales and Growth (2012-2017)
Figure India Neurological Biomarkers Sales and Growth (2012-2017)
Figure Southeast Asia Neurological Biomarkers Sales and Growth (2012-2017)
Figure South America Neurological Biomarkers Revenue and Growth (2012-2017)
Table South America Neurological Biomarkers Sales by Countries (2012-2017)
Table South America Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Figure South America Neurological Biomarkers Sales Market Share by Countries in 2016
Table South America Neurological Biomarkers Revenue by Countries (2012-2017)
Table South America Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure South America Neurological Biomarkers Revenue Market Share by Countries in 2012
Figure South America Neurological Biomarkers Revenue Market Share by Countries in 2016
Figure Brazil Neurological Biomarkers Sales and Growth (2012-2017)
Figure Argentina Neurological Biomarkers Sales and Growth (2012-2017)
Figure Columbia Neurological Biomarkers Sales and Growth (2012-2017)
Figure Middle East and Africa Neurological Biomarkers Revenue and Growth (2012-2017)
Table Middle East and Africa Neurological Biomarkers Sales by Countries (2012-2017)
Table Middle East and Africa Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Neurological Biomarkers Sales Market Share by Countries in 2016
Table Middle East and Africa Neurological Biomarkers Revenue by Countries (2012-2017)
Table Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries in 2012
Figure Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries in 2016
Figure Saudi Arabia Neurological Biomarkers Sales and Growth (2012-2017)
Figure UAE Neurological Biomarkers Sales and Growth (2012-2017)
Figure Egypt Neurological Biomarkers Sales and Growth (2012-2017)
Figure Nigeria Neurological Biomarkers Sales and Growth (2012-2017)
Figure South Africa Neurological Biomarkers Sales and Growth (2012-2017)
Table Global Neurological Biomarkers Sales by Type (2012-2017)
Table Global Neurological Biomarkers Sales Share by Type (2012-2017)
Table Global Neurological Biomarkers Revenue by Type (2012-2017)
Table Global Neurological Biomarkers Revenue Share by Type (2012-2017)
Figure Global Proteomics Sales Growth (2012-2017)
Figure Global Proteomics Price (2012-2017)
Figure Global Genomics Sales Growth (2012-2017)
Figure Global Genomics Price (2012-2017)
Figure Global Imaging Sales Growth (2012-2017)
Figure Global Imaging Price (2012-2017)
Figure Global Bioinformatics Sales Growth (2012-2017)
Figure Global Bioinformatics Price (2012-2017)
Figure Global Others Sales Growth (2012-2017)
Figure Global Others Price (2012-2017)
Table Global Neurological Biomarkers Sales by Application (2012-2017)
Table Global Neurological Biomarkers Sales Share by Application (2012-2017)
Figure Global Diagnostics Sales Growth (2012-2017)
Figure Global Drug Discovery Sales Growth (2012-2017)
Figure Global Personalized Medicine Sales Growth (2012-2017)
Figure Global Others Sales Growth (2012-2017)
Figure Global Neurological Biomarkers Sales, Revenue and Growth Rate (2017 -2022)
Table Global Neurological Biomarkers Sales Forecast by Regions (2017-2022)
Table Global Neurological Biomarkers Market Share Forecast by Regions (2017-2022)
Figure North America Sales Neurological Biomarkers Market Forecast (2017-2022)
Figure Europe Sales Neurological Biomarkers Market Forecast (2017-2022)
Figure Asia-Pacific Sales Neurological Biomarkers Market Forecast (2017-2022)
Figure South America Sales Neurological Biomarkers Market Forecast (2017-2022)
Figure Middle East and Africa Sales Neurological Biomarkers Market Forecast (2017-2022)
Table Global Neurological Biomarkers Sales Forecast by Type (2017-2022)
Table Global Neurological Biomarkers Market Share Forecast by Type (2017-2022)
Table Global Neurological Biomarkers Sales Forecast by Application (2017-2022)
Table Global Neurological Biomarkers Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の神経学的lバイオマーカー市場:メーカー別、地域別、種類別、用途別、市場予測(Global Neurological Biomarkers Market by Manufacturers, Countries, Type and Application, Forecast to 2022)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆